275. Carol E. Koro, “The independent correlation
function in Japanese. Lancet 1980;2:1132—1133.
between high—density lipoprotez‘n cholesterol and
286. Kagawa Y: Eicosapolyenoîc acids of serum,
subsequem‘ major adverse cofonaïy events”7
pidS—-OfJpïlêSô islanders With lOW incidence
American Heart Joumal —Volume 151, Issue 3,
of cardio vascular diseases. J Nutr Sci V1taminol
Pages 755.e1—755.e6 (March 2006).
1982, 28:
276. Vahouny GV, Ktchevsky D. Plant and marine
287. J assby, Alan : Nuüitional and Therapeutic Pro-“
and cholesterol metabolism. Nutr Phar—
perties of Spirulina. Proteus Corp. 1983. Crisa,
macol. 1981; 31—72. Simons, L.A., et al. On the
D. : Gamma—hnolenic acid, avita1nüüient Health
effects of dietary n—3 fatty acids (MaxEPA) on
Naturally, November/December 1992.
plasma lipids and lipoproteins in patients With
288. du département de Gastrologie et de Nutrition
hyperpidaemia AtheroSclerosis, Vol. 54, January
'
de la Harvard Medical School & MassachuSeüs
.
1985, pp. 75- 88.Adler,Adam J. and Holub, Bruce
'
General Hospital.
_
J. Effect of garlic and sh—oil supplementaüon
289. KushakR et al. Favorable e"ecls ofblue—green
on serum lipid and lipoprotein concentrations in
algue Aphanizomenonos—aqaæ on ral plasma
hypercholestero]emic men. American Journal of
lipids. Journal of the American Nutracentica'l
Clinical Nutrition, Vol. 65, February 1997, pp.
Association. January 2000; 2(3):59—65.
445-50.
-
'
'
290. Cohen Z, Norman H, HeimerY. Microalgae
277. Pollak OJ. Successful prevention of expe—
as a source of omega three fatty acids. Plants in
rimental hypercholesterolemia and choleste—
Human Nutrion.'1995; 77:1—31 '
.3 2 4
rol atherosclerosis in the rabbit. Circulation.
291- du Laboratory for Micro—algal Biotechnology
1953;2:696—701. Pollak OJ. Reduction ofblood
en Israel.
'
cholesterol in man. Circulation. 1953;2:702—
292. du Weed Science Laboratory at the United
706. Lees AM, Mok HYI, Lees RS, et al. Plant
States Department ofAgriculture.
sterols as cholesterol—loweng agents: clinical
292+. Deug R, Chow TJ;
an—
trials in patients With
tioxidant, and anti—inammat0ry activities of
and studies of sterol balance. Atherosclerosis.
microalgae Spirilina”; Cardiovasc Then 2010
1977;28:325—338. V.‘ W. Lau, M. Joumoud,
Aùg;28(4)ze33—45 '
=
,
'
and P. J. Jones: Plant sterols are ei0acious in
293. SukenikA,Takahashi H, Mokady S. Dietary
lowering plasma LDL and on—HDL choleste—
lipids from marine uniceular algae-enhance the
rol in hypercholesterolec type 2 diabetic and
amount of liver and
fatty acids in
nondiabetic persons, Am. J
.
Clinical Nutrition,
rats. Annals of Nutrition and Metabolism. 1994;
June 1, 2005; 81(6): 1351 — 1358.
,
=
'
38(2):85-96.
'
‘
'
278 journal of america medical association n°—sept
294. professeur de Chimie, Saddlcback college, 611
2004
_
Californie et auteur deAlgae to the Rescue. Logan
279. T. Kate and K. Takemoto : Effects of spirana
House, USA, 1996. -
f
_
on hypercholesterolemia and fatty liver in rats,
2951 cf._Hudson & Karis « The Lipids of the Alga '
\cu
Saitama Medical College, Japan Nan: Foods
Spinîlina » J. Sc. Fd. Agr. 25 — 1974
-l-'
Assoc. Journal, 1984, 37 1323.
.
29/6KN. Nayaka & coll. Tokai Univ. Pub in Progr. In
%
280. M.A. Devi and L.V. Venkatar‘ainan : Hypocho—.
/ »Medicine 1986 vol. 36 N°- 11 etNuttion Reports
m
lesterolemic e‘ect of blue—green algae spirana …. ‘ Int’l, 1988 vol. 37 N° 6
,
’
GJ
spiruIina in albino rats, Nutrition Reports Inter—
296 +. Samuels R, Man—i UV,
UM &
“c
national, 1983, 28 :519—530. '
_
'
'
coll. ;”Hypocholesterolemic effect of spirana
q)
281. Mani UV, Desai S, Iÿer U. Studies on the long—
-
'
in patients With hyperlipidemic nephtdtic syn3
term eœt of spirulina supplementaon on serum
drome”; J Med Feed. 2002 Sumg5(2)291;6
Æ
lipid prole and glycated proteins in N1DDM
297. Al_tschul R; HoerA; StephenJD :Inuence of
..Q
patients. J Nutraceut 200032(3):25-32_
—
niconic acid on serum Cholesterol in man. Arch
G)
282. N. Nayaka, et al.: Cholesterollcweng‘eect
Bi00hem Biophys 1955, 54: 558—559.
3
ofspirulina; Tokai Univ. Nutrition Reports Ihter—
298. ParsonsWB: Changesinconœnüaon ofblood
_?
national, 1988, Vol. 37, No. 6,’ 1329—1337
.
'
lipids following prolonged administraüon'oflarge
65
283. Kromann N: Epidemi010gical studies in the
doses of niconic acid to persons with hypercho—
:—
-
Upemavik district, Greenland. Incidence ofsome
lesterolemja : preliminary observations. Mayo
…"
chronic diseases 1950—1 974. Acta Med Scand.
Clin Proc 1956‘Ju 27,31‘Î13):377—90.
'
:
1980, 208(5):401—406.
299. erge KG: Coronary drug project: experience
:
284. Bang HO &Dyerbe'rg J : Lipid metabolism and
With niacin. Coronary Drug Project Research
E
ischemichea disease in Greenland Eskimos.Adv
Group. Eur J Clin Pharmacol. 1991;40 Supp1
-a
Nutr Res 1980, 3,1—22.111. '
*
'
‘
1 1849—51
*
*
_
'
m
285. Hirai A: Eicosapent‘aènoîc acid and platelet
300. «Dr. Atkins ’Age—Dfl‘ng Diet Revolution »
function in Japanese. Lancet 1980;2:1132—1133.
between high—density lipoprotez‘n cholesterol and
286. Kagawa Y: Eicosapolyenoîc acids of serum,
subsequem‘ major adverse cofonaïy events”7
pidS—-OfJpïlêSô islanders With lOW incidence
American Heart Joumal —Volume 151, Issue 3,
of cardio vascular diseases. J Nutr Sci V1taminol
Pages 755.e1—755.e6 (March 2006).
1982, 28:
276. Vahouny GV, Ktchevsky D. Plant and marine
287. J assby, Alan : Nuüitional and Therapeutic Pro-“
and cholesterol metabolism. Nutr Phar—
perties of Spirulina. Proteus Corp. 1983. Crisa,
macol. 1981; 31—72. Simons, L.A., et al. On the
D. : Gamma—hnolenic acid, avita1nüüient Health
effects of dietary n—3 fatty acids (MaxEPA) on
Naturally, November/December 1992.
plasma lipids and lipoproteins in patients With
288. du département de Gastrologie et de Nutrition
hyperpidaemia AtheroSclerosis, Vol. 54, January
'
de la Harvard Medical School & MassachuSeüs
.
1985, pp. 75- 88.Adler,Adam J. and Holub, Bruce
'
General Hospital.
_
J. Effect of garlic and sh—oil supplementaüon
289. KushakR et al. Favorable e"ecls ofblue—green
on serum lipid and lipoprotein concentrations in
algue Aphanizomenonos—aqaæ on ral plasma
hypercholestero]emic men. American Journal of
lipids. Journal of the American Nutracentica'l
Clinical Nutrition, Vol. 65, February 1997, pp.
Association. January 2000; 2(3):59—65.
445-50.
-
'
'
290. Cohen Z, Norman H, HeimerY. Microalgae
277. Pollak OJ. Successful prevention of expe—
as a source of omega three fatty acids. Plants in
rimental hypercholesterolemia and choleste—
Human Nutrion.'1995; 77:1—31 '
.3 2 4
rol atherosclerosis in the rabbit. Circulation.
291- du Laboratory for Micro—algal Biotechnology
1953;2:696—701. Pollak OJ. Reduction ofblood
en Israel.
'
cholesterol in man. Circulation. 1953;2:702—
292. du Weed Science Laboratory at the United
706. Lees AM, Mok HYI, Lees RS, et al. Plant
States Department ofAgriculture.
sterols as cholesterol—loweng agents: clinical
292+. Deug R, Chow TJ;
an—
trials in patients With
tioxidant, and anti—inammat0ry activities of
and studies of sterol balance. Atherosclerosis.
microalgae Spirilina”; Cardiovasc Then 2010
1977;28:325—338. V.‘ W. Lau, M. Joumoud,
Aùg;28(4)ze33—45 '
=
,
'
and P. J. Jones: Plant sterols are ei0acious in
293. SukenikA,Takahashi H, Mokady S. Dietary
lowering plasma LDL and on—HDL choleste—
lipids from marine uniceular algae-enhance the
rol in hypercholesterolec type 2 diabetic and
amount of liver and
fatty acids in
nondiabetic persons, Am. J
.
Clinical Nutrition,
rats. Annals of Nutrition and Metabolism. 1994;
June 1, 2005; 81(6): 1351 — 1358.
,
=
'
38(2):85-96.
'
‘
'
278 journal of america medical association n°—sept
294. professeur de Chimie, Saddlcback college, 611
2004
_
Californie et auteur deAlgae to the Rescue. Logan
279. T. Kate and K. Takemoto : Effects of spirana
House, USA, 1996. -
f
_
on hypercholesterolemia and fatty liver in rats,
2951 cf._Hudson & Karis « The Lipids of the Alga '
\cu
Saitama Medical College, Japan Nan: Foods
Spinîlina » J. Sc. Fd. Agr. 25 — 1974
-l-'
Assoc. Journal, 1984, 37 1323.
.
29/6KN. Nayaka & coll. Tokai Univ. Pub in Progr. In
%
280. M.A. Devi and L.V. Venkatar‘ainan : Hypocho—.
/ »Medicine 1986 vol. 36 N°- 11 etNuttion Reports
m
lesterolemic e‘ect of blue—green algae spirana …. ‘ Int’l, 1988 vol. 37 N° 6
,
’
GJ
spiruIina in albino rats, Nutrition Reports Inter—
296 +. Samuels R, Man—i UV,
UM &
“c
national, 1983, 28 :519—530. '
_
'
'
coll. ;”Hypocholesterolemic effect of spirana
q)
281. Mani UV, Desai S, Iÿer U. Studies on the long—
-
'
in patients With hyperlipidemic nephtdtic syn3
term eœt of spirulina supplementaon on serum
drome”; J Med Feed. 2002 Sumg5(2)291;6
Æ
lipid prole and glycated proteins in N1DDM
297. Al_tschul R; HoerA; StephenJD :Inuence of
..Q
patients. J Nutraceut 200032(3):25-32_
—
niconic acid on serum Cholesterol in man. Arch
G)
282. N. Nayaka, et al.: Cholesterollcweng‘eect
Bi00hem Biophys 1955, 54: 558—559.
3
ofspirulina; Tokai Univ. Nutrition Reports Ihter—
298. ParsonsWB: Changesinconœnüaon ofblood
_?
national, 1988, Vol. 37, No. 6,’ 1329—1337
.
'
lipids following prolonged administraüon'oflarge
65
283. Kromann N: Epidemi010gical studies in the
doses of niconic acid to persons with hypercho—
:—
-
Upemavik district, Greenland. Incidence ofsome
lesterolemja : preliminary observations. Mayo
…"
chronic diseases 1950—1 974. Acta Med Scand.
Clin Proc 1956‘Ju 27,31‘Î13):377—90.
'
:
1980, 208(5):401—406.
299. erge KG: Coronary drug project: experience
:
284. Bang HO &Dyerbe'rg J : Lipid metabolism and
With niacin. Coronary Drug Project Research
E
ischemichea disease in Greenland Eskimos.Adv
Group. Eur J Clin Pharmacol. 1991;40 Supp1
-a
Nutr Res 1980, 3,1—22.111. '
*
'
‘
1 1849—51
*
*
_
'
m
285. Hirai A: Eicosapent‘aènoîc acid and platelet
300. «Dr. Atkins ’Age—Dfl‘ng Diet Revolution »